Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2025-08-04
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mucosal Impedance and Eosinophilic Esophagitis
NCT01953575
Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients
NCT01641913
Study of Gastric Motility in Eosinophilic Gastritis
NCT05229432
Natural History of Eosinophilic Esophagitis
NCT03290482
Endoscopic Full Thickness Biopsy, Gastric Wall.
NCT01650714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controls
Subjects who can swallow normally
Surface Electromyography
Tests performed to evaluate swallowing function
Fiberoptic Endoscopic Evaluation of Swallowing
Assessment of swallowing function
Eosinophilic Esophagitis
Subjects with Eosinophilic Esophagitis
Surface Electromyography
Tests performed to evaluate swallowing function
Fiberoptic Endoscopic Evaluation of Swallowing
Assessment of swallowing function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surface Electromyography
Tests performed to evaluate swallowing function
Fiberoptic Endoscopic Evaluation of Swallowing
Assessment of swallowing function
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal video swallow or score of 0 for dysphagia on ESSAI questionnaire
* absence of dysphagia
* age \>18 EoE participants
* Documentation of EoE diagnosis by histologic criteria,
* \>15 eos/hpf on most recent esophageal biopsy
* age \>18
Exclusion Criteria
* lack of MSK coordination to eat test meal
* underlying neuromuscular disorder.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karthik Ravi, M.D.
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karthik Ravi, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-009832
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.